NEU 2.42% $19.38 neuren pharmaceuticals limited

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-177

  1. 100 Posts.
    lightbulb Created with Sketch. 3
    Well done to all holders and thanks for the insights over the past decade.

    I really hope they circle back to TBI at some stage.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.